Senate bill aims for FDA reform

04/18/2012 | Forbes

Sens. Tom Coburn, R-Okla., and Richard Burr, R-N.C., introduced a bill aimed at improving the FDA's internal management as well as accountability in regulating drugs and medical devices. The Patients' FDA Act would relax restrictions on companies' ties with physicians and speed up product-approval review. The proposal is meant to be part of the Prescription Drug and User Fee Act reauthorization.

View Full Article in:

Forbes

Published in Briefs: